SUBSCRIBE
SUBSCRIBE
News   FDA

Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Venlafaxine Extended Release Tablets

August 19, 2010 | 
1 min read
MUMBAI, India--(BUSINESS WIRE)--Sun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets.
FDA Approvals Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Unvaccinated And vaccinated people as anti-vaxxer or individuals that oppose taking the vaccine with 3D illustration elements.
Vaccines
FDA Plans Black Box Warning for COVID-19 Vaccines: Report
December 12, 2025
 · 
3 min read
 · 
Heather McKenzie
Pictured: Illustration of antibodies attacking a nerve cell
Approvals
Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis
December 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Hands in black and white dropping a collection of pills on a pink background
Approvals
GSK’s Blujepa Opens First New Class of Gonorrhea Antibiotic in More Than 30 Years
December 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Thumb up close-up in surgical, medical gloves, gesture, recommendation for a successful operation. Pink background.
Rare diseases
FDA Greenlights First Gene Therapy for Rare Pediatric Disease
December 10, 2025
 · 
1 min read
 · 
Tristan Manalac